The SAFEST Study: Survey on Antiplatelets in Flow Diversion for Aneurysm Endovascular Treatment.

ABSTRACT:

Background

Flow diversion has emerged as a promising treatment strategy for intracranial aneurysms, yet the influence of antiplatelet therapy on treatment outcomes remains uncertain. Regional and institutional variability in antiplatelet regimens further complicates treatment standardization. This survey aimed to investigate common practices of antiplatelet medication usage in flow diversion for intracranial aneurysms worldwide.

Methods

An anonymous online survey explored antiplatelet therapy regimens in flow diverter implantations, including agent selection, dosing, and duration. The survey was distributed through international neurointerventional societies and mailing lists.

Results

Participants included 442 from 53 countries, revealing that most practitioners agree

SUBMITTER: Hohenstatt S 

PROVIDER: S-EPMC11864745 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature